메뉴 건너뛰기




Volumn 52, Issue 10, 2008, Pages 3478-3483

Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DORIPENEM; DORIPENEM C 14; UNCLASSIFIED DRUG;

EID: 54049157482     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00424-08     Document Type: Article
Times cited : (37)

References (19)
  • 1
    • 33746225229 scopus 로고    scopus 로고
    • Doripenem
    • Anderson, D. L. 2006. Doripenem. Drugs Today 42:399-404.
    • (2006) Drugs Today , vol.42 , pp. 399-404
    • Anderson, D.L.1
  • 2
    • 24144496190 scopus 로고    scopus 로고
    • Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem
    • Bhavnani, S. M., J. P. Hammel, B. B. Cirincione, M. A. Wikler, and P. G. Ambrose. 2005. Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem. Antimicrob. Agents Chemother. 49:3944-3947.
    • (2005) Antimicrob. Agents Chemother , vol.49 , pp. 3944-3947
    • Bhavnani, S.M.1    Hammel, J.P.2    Cirincione, B.B.3    Wikler, M.A.4    Ambrose, P.G.5
  • 4
    • 0030049979 scopus 로고    scopus 로고
    • Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin
    • Dreetz, M., J. Hamacher, and J. Eller. 1996. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Antimicrob. Agents Chemother. 40:105-109.
    • (1996) Antimicrob. Agents Chemother , vol.40 , pp. 105-109
    • Dreetz, M.1    Hamacher, J.2    Eller, J.3
  • 5
    • 2142760947 scopus 로고    scopus 로고
    • Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug.' Nat. Rev. Microbiol
    • Drusano, G. L. 2004. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug.' Nat. Rev. Microbiol. 2:289-300.
    • (2004) , vol.2 , pp. 289-300
    • Drusano, G.L.1
  • 6
    • 28644447594 scopus 로고    scopus 로고
    • Antimicrobial activity of doripenem (S-4661): A global surveillance report (2003)
    • Fritsche, T. R., M. G. Stilwell, and R. N. Jones. 2005. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). Clin. Microbiol. Infect. 11:974-984.
    • (2005) Clin. Microbiol. Infect , vol.11 , pp. 974-984
    • Fritsche, T.R.1    Stilwell, M.G.2    Jones, R.N.3
  • 9
    • 30844454044 scopus 로고    scopus 로고
    • Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals
    • Hori, T., M. Nakano, Y. Kimura, and F. Murakami. 2006. Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals. In Vivo 20:91-96.
    • (2006) In Vivo , vol.20 , pp. 91-96
    • Hori, T.1    Nakano, M.2    Kimura, Y.3    Murakami, F.4
  • 10
    • 3342910269 scopus 로고    scopus 로고
    • Activities of doripenem (S-4661) against drug-resistant clinical pathogens
    • Jones, R. N., H. K. Huynh, and D. J. Biedenbach. 2004. Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrob. Agents Chemother. 48:3136-3140.
    • (2004) Antimicrob. Agents Chemother , vol.48 , pp. 3136-3140
    • Jones, R.N.1    Huynh, H.K.2    Biedenbach, D.J.3
  • 11
    • 18844415653 scopus 로고    scopus 로고
    • Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli and various β-lactamase resistance mechanisms
    • Jones, R. N., H. S. Sader, and T. R. Fritsche. 2005. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli and various β-lactamase resistance mechanisms. Diagn. Microbiol. Infect. Dis. 52:71-74.
    • (2005) Diagn. Microbiol. Infect. Dis , vol.52 , pp. 71-74
    • Jones, R.N.1    Sader, H.S.2    Fritsche, T.R.3
  • 12
    • 34548177850 scopus 로고    scopus 로고
    • Uniformly enhanced activity of doripenem compared to other carbapenems (imipenem, meropenem) when testing P. aeruginosa isolates: Results from three continents
    • Abstract
    • Jones, R. N., M. G. Stillwell, H. S. Sader, and T. R. Fritsche. 2006. Uniformly enhanced activity of doripenem compared to other carbapenems (imipenem, meropenem) when testing P. aeruginosa isolates: results from three continents. Int. J. Infect. Dis. 10(Suppl. 1):S127-S128. (Abstract.)
    • (2006) Int. J. Infect. Dis , vol.10 , Issue.SUPPL. 1
    • Jones, R.N.1    Stillwell, M.G.2    Sader, H.S.3    Fritsche, T.R.4
  • 13
    • 0030977235 scopus 로고    scopus 로고
    • Pharmacokinetics of meropenem in animals, healthy volunteers, and patients
    • Moon, Y. S. K., K. C. Chung, and M. A. Gill. 1997. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Clin. Infect. Dis. 24(Suppl. 2):S249-S255.
    • (1997) Clin. Infect. Dis , vol.24 , Issue.SUPPL. 2
    • Moon, Y.S.K.1    Chung, K.C.2    Gill, M.A.3
  • 14
    • 0033804883 scopus 로고    scopus 로고
    • Comparative pharmacokinetics of the carbapenems. Clinical implications
    • Mouton, J. W., D. J. Touw, A. M. Horrevorts, and A. A. Vinks. 2000. Comparative pharmacokinetics of the carbapenems. Clinical implications. Clin. Pharmacokinet. 39:185-201.
    • (2000) Clin. Pharmacokinet , vol.39 , pp. 185-201
    • Mouton, J.W.1    Touw, D.J.2    Horrevorts, A.M.3    Vinks, A.A.4
  • 15
    • 1642502313 scopus 로고    scopus 로고
    • Comparative activities of doripenem versus isolates, mutants, and transconjugates of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases
    • Mushtaq, S., Y. Ge, and D. M. Livermore. 2004. Comparative activities of doripenem versus isolates, mutants, and transconjugates of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases. Antimicrob. Agents Chemother. 48:1313-1319.
    • (2004) Antimicrob. Agents Chemother , vol.48 , pp. 1313-1319
    • Mushtaq, S.1    Ge, Y.2    Livermore, D.M.3
  • 17
    • 33744950954 scopus 로고    scopus 로고
    • Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa. The high potency of a new carbapenem doripenem
    • Sakyo, S., H. Tomita, K. Tanimoto, S. Fujimoto, and Y. Ike. 2006. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa. The high potency of a new carbapenem doripenem. J. Antibiot. 59:220-228.
    • (2006) J. Antibiot , vol.59 , pp. 220-228
    • Sakyo, S.1    Tomita, H.2    Tanimoto, K.3    Fujimoto, S.4    Ike, Y.5
  • 19
    • 33846798522 scopus 로고    scopus 로고
    • Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem
    • Yamano, Y., T. Nishikawa, T. Fujimura, T. Yutsudou, M. Tsuji, and H. Miwa. 2006. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem. J. Antibiot. 59:791-796.
    • (2006) J. Antibiot , vol.59 , pp. 791-796
    • Yamano, Y.1    Nishikawa, T.2    Fujimura, T.3    Yutsudou, T.4    Tsuji, M.5    Miwa, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.